Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical safety and efficacy of Loteprednol Etabonate Ophthalmic Ointment,
0.5% vs. vehicle for the treatment of inflammation following cataract surgery